359 related articles for article (PubMed ID: 10923640)
1. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
Alessi MC; Bastelica D; Morange P; Berthet B; Leduc I; Verdier M; Geel O; Juhan-Vague I
Diabetes; 2000 Aug; 49(8):1374-80. PubMed ID: 10923640
[TBL] [Abstract][Full Text] [Related]
2. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.
Samad F; Yamamoto K; Pandey M; Loskutoff DJ
Mol Med; 1997 Jan; 3(1):37-48. PubMed ID: 9132278
[TBL] [Abstract][Full Text] [Related]
4. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.
Alessi MC; Peiretti F; Morange P; Henry M; Nalbone G; Juhan-Vague I
Diabetes; 1997 May; 46(5):860-7. PubMed ID: 9133556
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
6. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
Eriksson P; Van Harmelen V; Hoffstedt J; Lundquist P; Vidal H; Stemme V; Hamsten A; Arner P; Reynisdottir S
Thromb Haemost; 2000 Apr; 83(4):545-8. PubMed ID: 10780314
[TBL] [Abstract][Full Text] [Related]
7. Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes.
Birgel M; Gottschling-Zeller H; Röhrig K; Hauner H
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1682-7. PubMed ID: 10845889
[TBL] [Abstract][Full Text] [Related]
8. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture.
Gottschling-Zeller H; Birgel M; Röhrig K; Hauner H
Metabolism; 2000 May; 49(5):666-71. PubMed ID: 10831181
[TBL] [Abstract][Full Text] [Related]
9. Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women.
Polac I; Cierniewska-Cieslak A; Stachowiak G; Pertynski T; Cierniewski CS
Thromb Res; 2001 Jun; 102(5):397-405. PubMed ID: 11395125
[TBL] [Abstract][Full Text] [Related]
10. PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.
Morange PE; Alessi MC; Verdier M; Casanova D; Magalon G; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1361-5. PubMed ID: 10323791
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1.
Samad F; Uysal KT; Wiesbrock SM; Pandey M; Hotamisligil GS; Loskutoff DJ
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6902-7. PubMed ID: 10359811
[TBL] [Abstract][Full Text] [Related]
12. Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha?
Cigolini M; Tonoli M; Borgato L; Frigotto L; Manzato F; Zeminian S; Cardinale C; Camin M; Chiaramonte E; De Sandre G; Lunardi C
Atherosclerosis; 1999 Mar; 143(1):81-90. PubMed ID: 10208482
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of tumor necrosis factor-alpha-mediated plasminogen activator inhibitor-1 expression in adipocytes.
Pandey M; Loskutoff DJ; Samad F
FASEB J; 2005 Aug; 19(10):1317-9. PubMed ID: 15928193
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
[TBL] [Abstract][Full Text] [Related]
15. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
[TBL] [Abstract][Full Text] [Related]
16. PAI-1 and TNF-α profiles of adipose tissue in obese cardiovascular disease patients.
Bilgic Gazioglu S; Akan G; Atalar F; Erten G
Int J Clin Exp Pathol; 2015; 8(12):15919-25. PubMed ID: 26884864
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.
Shimomura I; Funahashi T; Takahashi M; Maeda K; Kotani K; Nakamura T; Yamashita S; Miura M; Fukuda Y; Takemura K; Tokunaga K; Matsuzawa Y
Nat Med; 1996 Jul; 2(7):800-3. PubMed ID: 8673927
[TBL] [Abstract][Full Text] [Related]
19. Human visceral adipose tissue and the plasminogen activator inhibitor type 1.
Lindeman JH; Pijl H; Toet K; Eilers PH; van Ramshorst B; Buijs MM; van Bockel JH; Kooistra T
Int J Obes (Lond); 2007 Nov; 31(11):1671-9. PubMed ID: 17471294
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
Koistinen HA; Dusserre E; Ebeling P; Vallier P; Koivisto VA; Vidal H
Diabetes Metab Res Rev; 2000; 16(5):364-9. PubMed ID: 11025560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
